News About: Pharm. Affairs
It is definite that CEO Han-gi Kim of Sinsin Pharm will be the new president of the Korea Pharmaceutical Traders Association
It is definite that the Korea Pharmaceutical Traders Association (KPTA)will newly appoint CEO Han-gi Kim (63 year old) of Sinsin Pharm.
CEO Kim has worked as a chief vice president of the KPTA for the past 3 years.
...
The TSEC, ‘Duavive’, has been revealed…“Its strong point is safety”The new menopausal symptom treatment uncovered its veil. Pfizer has launched the menopausal symptom treatment ‘Duavive’.
Duaviveattractedattention through the TSEC (tissue sele...
|
Master-level treatments?...the pharmaceutical industry is also concerning the first recruitment of 6-year college graduates of pharmacy
Although the pharmaceutical industry is desperate to recruit pharmacists in the R&D and clinical fields, college pharmacy graduates actually hesitate to apply for the pharmaceutical industry. Pharmaceutical companies ...
Hepatitis type C treatments are expected to be the hot issue in the industry
Hepatitis type C treatments, attracting attention in the industry concerned, will become the hot issue in the second half of the year.
There is a higher chance the second generation hepatitis type B treatments will c...
“Let’s increase the chance to develop new drugs”…Hospitals tend to construct MOUs.
Again in this year, university hospitals have signed memorandums of understanding (MOU) with various institutions. Their goals are to increase chances of ‘new drugs’through using expertise of hospitals on the clinical...
Domestic pharmaceutical products have remained strong in the painkiller market… Geworin and Penzal have kept their momentum
Domestic pharmaceutical products, such as ‘Geworin’ and ‘Penzal’, remain strong in the recent painkiller market.
According to the recent IMS data, it is observed that the Johnson & Johnson’s Tylenol stayed the top on...
The hepatitis type A NIP will include Sanofi Pasteur, GSK and MSD
The Ministry of Health and Welfare (Minister Hyung-pyo Moon) held the Health Technology Policy Deliberation Committee (chairwoman: professor Sun-young Kim, Life Science Department, Seoul National University) to finali...
Expansion of the lineup with Kanarb complexes… a clinical trial of combining it with Lipitor
Boryung Pharmaceutical is advancing on clinical trials to expand its lineup with the self-developed hypertension treatment ‘Kanarb’ complex.
According to the Ministry of Food and Drug Safety on the 28th, Boryung Phar...
Will Palpal exceed Cialis? The industry has paid attention on impotence treatments
The industry concerned paid attention on the Palpal’s (Hanmi Pharmaceutical) direction to exceed over the top impotence treatment ‘Cialis’.
In various indexes, there is higher possibility Palpalwill take the lead. Th...
Doctors are positive about the SGLT-2 inhibitor…“Yet, it lacks in patient cases”
The treatment industry for ‘diabetes’, considered as one of the chronic diseases, has begun a new changing era. So far, the existing diabetes treatments have had side effects of weight increases and hypoglycemia.
How...
